Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ulixertinib
Plasma Cell Myeloma
National Cancer Institute (NCI)
P2
CC
(43)
18f-flt
Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Esthesioneuroblastoma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Digestive System Neuroendocrine Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Head And Neck Cancer
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Kidney Cancer
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Olfactory Neuroblastoma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Pheochromocytoma-Paraganglioma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Abatacept Recombinant
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Abatacept Recombinant
Peripheral T-Cell Lymphoma, Not Otherwise Specified
National Cancer Institute (NCI)
P1
CC
(43)
Abatacept Recombinant
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Abemaciclib
Nut Midline Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Adriamycin
Appendix Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Adriamycin
Endometrial Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Adriamycin
Human T-Lymphotropic Virus 1 Infectious Disease
National Cancer Institute (NCI)
P1
CC
(43)
Adriamycin
Peritoneal Mesothelioma
National Cancer Institute (NCI)
P1
CC
(43)
Adriamycin
Cancer Or Benign Tumor
National Cancer Institute (NCI)
P1
CC
(43)
Anti-Icos Monoclonal Antibody Medi-570
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Anti-Icos Monoclonal Antibody Medi-570
Angioimmunoblastic T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Anti-Icos Monoclonal Antibody Medi-570
Follicular Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Anti-Icos Monoclonal Antibody Medi-570
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Anti-Icos Monoclonal Antibody Medi-570
Mycosis Fungoides
National Cancer Institute (NCI)
P1
CC
(43)
Atezolizumab
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Showing 2676 to 2700 of 3,272 assets
Previous
Page 108 of 131
Next
